The Staged Treatment in Early Psychosis Study

Clinical trial NCT02751632 · COMPLETED

Trial details

NCT number: NCT02751632
Sponsor: Orygen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psychotic Disorders Personality Disorders Clinical High Risk

Start date: 2016-04-01
Primary completion: 2019-07-01
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.